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1. Introduction 
The human prostate epithelium, which is the histological origin of most prostate 
malignancies, is physically separated from the stroma by a layer of basal cells and the 
basement membrane. Basal cells are inter-connected by intercellular junctions and adhesion 
molecules, constituting a continuous sheet encircling luminal cells [1-2]. The basement 
membrane is composed of type IV collagen, laminins, and other molecules, forming a 
continuous lining surrounding and attaching to the basal cell layer [3-4] (Fig 1). The 
basement membrane and the basal cell layer are intermixed to form a dense fibrous capsule 
surrounding all epithelial cells. Due to these relationships, disruption of the basal cell layer 
and the basement membrane is a pre-requisite for tumor invasion or metastasis.  
It is a commonly held belief that prostate carcinogenesis progresses sequentially from 
normal to hyperplasia, to prostatic intraepithelial neoplasia (PIN), and to invasive or 
metastatic lesions [5-8]. Progression from PIN to invasion is believed to be triggered by 
overproduction of proteolytic enzymes primarily by cancer cells, which cause degradation 
of the tumor capsule [9-10]. These theories are consistent with laboratory findings from cell 
cultures and animal models, whereas are hard to reconcile with a number of critical facts. 
First, previous studies revealed that some healthy men between 19 and 29 years old had a 
spectrum of proliferative lesions, including hyperplasia, PIN, and incipient adenocarcinoma 
[11-13]. Second, recent studies have detected a DNA phenotype identical to that of invasive 
prostate cancer in some “healthy” men, and also in normal prostate tissues adjacent to 
prostate cancer [14-17]. Third, a majority of PIN express high levels of proteolytic enzymes, 
but only 10-30% of untreated PIN progress to invasive lesions during patients’ lifetime [18-
21]. Fourth, cancer of unknown primary site is one of the 10 most frequent cancers 
worldwide and the 4th most common cause of cancer deaths [22-24].  
Together, these facts argue that the linear model of carcinogenesis [5-8] and enzyme theory 
of tumor invasion [9-10] are not universally applicable to all prostate cancer cases. These 
facts also suggest that the past efforts to classify tumor progression and invasion purely 
based on the profiles of epithelial cells may have overlooked some essential factors. As over 
90% of prostate cancer related mortality result from invasion related diseases, and the 
incidence of PIN could be up to 16.5%-25% in prostate biopsies [25-27], there is an urgent 
www.intechopen.com
 Prostate Biopsy 
 
92
need to uncover the intrinsic mechanism of tumor invasion and to distinguish aggressive 
and indolent PIN for optimal or personalized treatment. Unfortunately, none of the current 
approaches could predict which PIN lesions will progress [28-31]. The only established 
approach to monitor PIN progression is repeat biopsy [28-31], which is costly and painful. 
 
 
Fig. 1. Structural relationships among the epithelium (circles), basal cell layer (thick arrows), 
basement membrane (thin arrows), and stroma (asterisks). Human prostate tissue sections 
were double immunostained for collagen IV (brown) and cytokeratin 34βE12 (red). A and C: 
150X. B and D: a higher (500X) magnification of A and C. 
Promoted by the fact that the basal cell layer is the sole source of tumor suppressor p63 and 
maspin [32-35], and that degradation of the basal cell layers is a pre-requisite for tumor 
invasion, our resent studies have attempted to identify early signs of basal cell degradation. 
Our initial study examined the physical integrity of the basal cell layers in 50 patients with 
co-existing pre-invasive and invasive prostate tumors. Of 2,047 ducts and acini examined, 
197 were found to harbor focal disruptions (the absence of basal cells resulting in a gap 
greater than the combined size of at least 3 basal cells) in their basal cell layers. The 
frequency of focal basal cell layer disruptions (FBCLD) varied from none in 22 (44%) cases to 
over 1/3 of the ducts or acini with FBCLD in 17 (34%) cases (Table 1) [36]. Of the 17 cases 
with a high frequency of FBCLD, 5 harbored large acinar or duct clusters that are 
morphologically normal in H& E stained sections, but all harbored focal disruptions in the 
surrounding capsule in immunostained sections. As shown in Fig 2a, each of the 12 
epithelial structures in one of such cases harbors FBCLD, but none of the 12 morphologically 
similar epithelial structures in Case B shows FBCLD.  
* 
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Case number No disruptions < 30% disruptions ≥ 30% disruptions p 
50 22 (44%) 11 (22%) 17 (34%) < 0.01 
Table 1. Frequencies of focal basal cell layer disruptions among cases 
 
 
(a)     (b) 
Fig. 2. Different frequencies of FBCLD among cases. Double immunostained for CK 34ßE12 
(red) and Ki-67 (brown). In Case A, all 12 epithelial structures show FBCLD (arrows), 
whereas in Case B, none shows FBCLD. 200X.  
Compared to their non-disrupted counterpart, focally disrupted basal cell layers in these 17 
cases displayed several unique alterations that were not or rarely seen in morphologically 
similar structures in other cases [36-44]: 
A. significantly reduced expression of tumor suppressor p63: In sections double 
immunostained for p63 and CK 34βE12, an average of 87% of the basal cells in non-
disrupted layers expressed both molecules, while only 59% of the basal cells in focally 
disrupted layers showed p63 expression (Fig 3; Table 2).  
 
 
(a)     (b) 
Fig. 3. Reduction of p63 expression in focally disrupted basal cell layers. Sections were 
double immunostained for CK 34ßE12 (red) and p63 (black). Thin and thick arrows identify 
cells with and without p63 expression, respectively. 400X.  
 Without FBCLD With FBCLD    With FBCLD 
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Basal cell layer status 
Number of ducts or 
acini 
Percentage of p63 (+) cells P 
With disruption 197 59% 
< 0.01 W/o disruption 197 87% 
Table 2. p63 expression in basal cell layers with and without focal disruption 
B. significantly reduced expression of proliferating cell nuclear antigen (PCNA): In 
sections double immunostained for PCNA and CK34βE12, an average of 74% of the normal 
basal cells showed PCNA expression, but only 51% of basal cells in disrupted basal layers 
showed PCNA expression (Fig. 4; Table 3).  
 
 
 
(a)     (b) 
Fig. 4. Significantly reduced PCNA expression in basal cell layers with FBCLD. Double 
immunostained for CK34 βE12 (red) and PCNA (black). Thin and thick arrows identify 
basal cells with and without PCNA expression, respectively. 400X 
 
Basal cell layer status 
Number of ducts or 
acini 
% of PCNA (+) cells P 
With disruption 50 51% 
< 0.01 W/o disruption 50 74% 
Table 3. PCNA expression in basal cell layers with and without focal disruption 
C. significantly elevated apoptosis and degeneration: Of 78 epithelial structures with 
FBCLD examined, 59 (75.6%) harbored apoptotic basal cells, compared to 9% (11.5%) in 78 
similar structures with intact basal layers. 
Under high magnification, basal cells near FBCLD often had cytological signs of 
degeneration, including nuclear swelling, shrinkage, fragmentation, or rod-like structures of 
fused basal cells (Fig. 5).  
 Without FBCLD    With FBCLD 
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Fig. 5. Elevated apoptosis and degeneration in focally disrupted basal cell layers. Section 
was assessed for apoptosis (a-b) or CK34βE12 expression (c-d). Arrows identify apoptotic or 
degenerated basal cells arranged as rod-like structures. 300X.  
D. significantly elevated leukocyte infiltration: In sections double immunostained for CK 
34βE12 and leukocyte common antigen (LCA), most structures with FBCLD showed 
leukocyte infiltration, but most structures with non-disrupted layers had no leukocyte 
infiltration (Table 4). Most leukocytes were located near FBCLD (Fig 6). 
 
 
(a)     (b) 
Fig. 6. FBCLD and infiltration of LCA=positive cells. Double immunostained for CK34βE12 
(red) and LCA (brown). Arrows identify infiltrates within the epithelium or near FBCLD. 
No leukocyte infiltration was seen in ducts with non-disrupted basal cell layers (asterisks). 
A; 100X. B: a higher (300X) magnification of A.  
(a)        (b) 
 *      * 
(c)        (d) 
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Basal cell layer status 
Number of ducts or 
acini 
Number of leukocyte 
infiltration 
P 
With focal disruptions 201 183 (91.0%) 
< 0.01 
Without focal 
disruptions 
201 67 (33.3%) 
Table 4. Leukocyte infiltration in epithelial structures with and without focal basal cell layer 
disruption 
E. a total loss of the expression of all basal cell phenotypic markers: In addition to focal 
alterations, the entire basal cell layer in some epithelial structures of some cases showed 
degenerative changes. These basal cell layers were morphologically distinct, surrounding 
PIN or normal-appearing duct or acinar clusters (Fig 7). All the basal cells, however, 
lacked the expression of basal cell specific markers (Fig 7). Epithelial associated with 
these basal cell layers often showed malignant cytology, including enlarged nuclei and 
nucleoli. 
 
 
CK34 ßE12                              p63                            Maspin PSA
CK-5                                  CK-14                              SMA                             CK-AE1/AE3
 
 
Fig. 7. Morphologically distinct basal cell layers lack expression of all basal cell specific 
markers. Immunostained for basal (a-e), stromal (f), and epithelial (g-h) cell markers. 
Arrows identify altered basal cell layers. 200X.  
In addition, these basal cell layers were devoid of expression of PCNA, in contrast to normal 
basal cells and associated tumor cells, which were strongly positive for PCNA (Fig. 8). 
Epithelial structures with altered basal cell layers often had mast cell infiltration, which was 
not seen in structures with intact basal cell layers (Fig 8). 
(a)           (c)      (e)               (g) 
(b)            (d)       (f)               (h) 
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Fig. 8. PNA expression and mast cell infiltration in acini with altered basal cell layers. 
Double immunostained for CK34 βE12 (red) and PCNA (brown) or mast cells (black). 
Arrows identify basal cells or mast cells. a & c: 100X. b & d: 400X. 
Together, these findings suggest that focally disrupted basal cell layers are likely to be under 
degeneration. As the basal cell layer is the sole source of several tumor suppressors [29-32], 
degenerated basal cells are very likely to have impaired or reduced paracrine inhibitory 
functions on tumor cell growth and invasion. In contrast to degenerative alterations in basal 
cells, luminal cells overlying FBCLD showed several signs of proliferative alterations that 
were not seen in their adjacent counterparts distant from the disruptions:  
A. significantly elevated proliferation: In section double immunostained for basal cell and 
proliferation markers, epithelial structures with FBCLD had a significantly higher 
proliferation index than their morphologically similar counterparts without FBCLD, and 
most proliferating cells were located at or near FBCLD (Fig.9; Table 5).  
 
Duct or acinar type Total number With proliferating cells P 
With disruption 78 47 (62.5%) 
< 0.01 W/o disruption 78 8 (10.2%) 
Table 5. Cell proliferation in epithelial structures with and without focal basal cell layer 
disruption 
 
 
Fig. 9. Increased proliferation in ducts with FBCLD. Sections were double immunostained 
for CK 34βE12 (red) and Ki-67 (brown). Arrows identify proliferating cell clusters. Note that 
in a-b, KI-67 positive cells are seen in ducts with FBCLD, but not in adjacent ducts without 
FBCLD (square). a & c: 100X. b & d: a higher (400X) magnification of a and c, respectively. 
(a)           (b)       (c)               (d) 
(a)           (b)       (c)               (d) 
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B. significantly higher expression of malignancy- and tumor invasion-related molecules: 
Elevated expression of prostate specific antigen (PSA) and alpha-methylacyl-CoA racemase 
(AMACR), are seen in cells overlying FBCLD (Fig.10a & b), and also in normal ducts lacked 
the expression of basal cell markers (Fig. 10c & d). In contrast, cells within the same duct, 
and adjacent ducts with intact basal cell layers were negative (Fig 10).  
 
 
 
 
Fig. 10. PSA and AMACR expression in cells overlying FBCLD and ducts with altered basal 
cells. Double immunostained for CK34 βE12 (red) and PSA or AMACR (brown). Thick 
arrows identify cells with AMACR or PSA expression. Thin arrows identify residual basal 
cells. a & c: 100X. b & d: a higher magnification (400X) of a & c, respectively.  
C. physical continuity with, and morphological resemblance to, invasive prostate cancer: 
A vast majority of these normal appearing acinar or duct clusters were immediately adjacent 
to, or blended with, invasive cancers. In some cases, cells overlying FBCLD had significantly 
enlarged nuclei and nucleoli, and were often in physical continuity with, or morphologically 
similar to, their adjacent invasive counterparts (Fig 11).  
In some cases, multiple epithelial cell nests appeared to be “budding” from the same acinus 
or duct (Fig.12). These “budding” cells had a higher proliferation and were similar to 
adjacent invasive cancer cells. The only difference was that “budding” cells are often 
associated with residual basal cells (Fig 12, thin arrows).  
(a) PSA    (b)   
 
(c) AMACR     (d) 
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(a)     (b) 
Fig. 11. Physical continuity with, and morphological resemblance to, invasive cancer. 
Double immunostained for CK 34ßE12 (red) and Ki-67 (brown). Circles identify 
proliferating cells overlying FBCLD. Note that cells overlying FBCLD are in direct 
continuity and similar to invasive cancer cells (arrows). Cells near FBCLD appear to invade 
a small and dilated vein (arrowhead). a: 100X. b: a higher (400X) magnification of a.  
 
 
Fig. 12. Cell “budding” from normal epithelial structures. Double immunostained for 
CK34βE12 (red) and Ki-67 (brown). Circles identify normal epithelial structures. Thick arrows 
identify “budding” cell clusters. Thin arrows identify residual basal cells. Asterisks identify 
invasive cancers. a & c: 100X. b & d: a higher (400X) magnification of a and c, respectively. 
 * 
(a)         (b) 
(c)         (d) 
 * 
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D. Significantly higher expression of chromogranin A: In sections double immunostained 
for CK 34βE12 and chromogranin A, a neuroendocrine differentiation-related marker 
correlating with tumor progression and the status of hormone refractoriness [45-47], 
chromogranin A positive cells were exclusively or preferentially seen in epithelial structures 
with FBCLD (Fig 13). Compared to morphologically similar counterparts, microdissected 
epithelial structures with chromogranin A-positive cell clusters had a more than 5- and 7-
fold lower expression of Micro-RNAs 146a and 146b-5p (miR-146a and miR-146b-5p; Fig 14), 
which have been documented to correlate with prostate tumor invasion and hormone 
refractoriness [38].  
 
 
 
 
 
 
 
 
 
 
Fig. 13. Chromogranin A positive cells preferentially in epithelial structures with FBCLD. 
Double immunostained for CK βE12 (red) and chromogranin A (black). Thick arrows 
identify FBCLD. Thin arrows identify chromogranin A-positive cells. Circle identifies 
residual basal cells. Asterisks identify epithelial structures with FBCLD.  
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Fig. 14. Correlative expression levels of miR- 146a and 146b-5p in microdissected epithelial 
structures with (B) and without chromogranin-A positive cell clusters (A). 
E. significantly elevated expression of tumor invasion-related genes: Compared to their 
adjacent counterpart associated with the residual basal cell layer within the same duct, 
microdissected cell clusters overlying FBCLD consistently had significantly higher 
expression of cell proliferation, apoptosis, angiogenesis, immuno-response, and stem cell 
related genes [38] (Fig 15; Table 6).  
 
 
 
 
 
Fig. 15. Different gene expression profiles in cells overlying FBCLD and adjacent 
counterparts. Cells from these two locations were microdissected from frozen prostate 
sections, and subjected to RNA extraction, amplification, and gene expression profiling 
using our published protocols. Circles identify microdissected cells and differentially 
expressed genes.  
a 
b
      a   b 
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# Gene name Potential functions Fold changes 
1 LIF Growth factor 47.37 
2 MCL1 Anti-apoptosis 6.72 
3 TNFRSF7 Anti-apoptosis 7.91 
4 KIT Stem cell lineage marker 5.03 
5 NCOR2 Stem cell lineage marker 5.45 
6 ENG Endothelial cell marker 6.38 
7 ICAM2 Endothelial cell marker 12.12 
8 KRT17 Epithelial cell marker 7.15 
9 ITGA3 Cell-matrix adhesion 5.52 
10 ITGB3 Cell-matrix adhesion 7.14 
11 CCL2 Chemokine, cytokine, and receptor 14.33 
12 CX3CL1 Chemokine, cytokine, and receptor 6.14 
13 CCR1 Chemokine, cytokine, and receptor 5.19 
14 CXCR4 Chemokine, cytokine, and receptor 12.81 
15 TNFRSF10D TNF receptor family 8.20 
16 TNFRSF12A TNF receptor family 5.35 
17 TNFRSF25 TNF receptor family 8.52 
18 TIMP1 ECM inhibitor 5.25 
19 TIMP3 ECM inhibitor 7.87 
20 MMP-26 Matrix metalloproteinase -6.94 
21 IL10 Interleukin and receptor -9.50 
22 IL12RB2 Interleukin and receptor -7.02 
23 IL6R Interleukin and receptor -7.24 
Table 6. Differentially expressed genes between cells overlying FBCLD and their adjacent cells 
The above alterations were consistently seen in all 17 cases with a high frequency of FBCLD, 
while were only seen in 1 (9.1%) of the 11 cases with a low frequency of FBCLD, and in none 
of the 22 cases with non-disrupted basal cell layers. Together, these findings suggest that the 
physical and functional status of the basal cell layer significantly impact the biological 
presentation of associated epithelial cells. These findings also suggest that malignant 
transformation and stromal invasion could occur in morphologically normal prostate 
tissues, and that FBCLD may represent a trigger factor for prostate tumor progression and 
invasion. To our best knowledge, our findings have not been previously reported by others. 
The most likely reasons are: [1] the enzyme theory has dominated the direction of researches 
in the field, and the roles of basal cells have been ignored, and [2] these alterations can be 
seen only by double immunohistochemistry to simultaneously elucidate the basal and 
epithelial cells. Double immunostaining, however, has not been commonly used in the 
clinical studies.  
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Our hypothesis of tumor invasion 
Based on the above findings, we strongly believe that these normal appearing epithelial 
structures represent a population of maturation arrested tumor progenitors derived from 
monoclonal proliferation of genetically altered primitive stem cells at early stages of the 
prostate morphogenesis probably by trauma, radiation, inflammation, or other factors. 
These clusters retain the potential for unlimited cell proliferation or multi-lineage 
differentiation, and could progress directly to invasive lesions through two pathways: (1) In 
situ malignant transformation, and (2) Progenitor-mediated cell budding. These pathways 
are likely to contribute to early onset of prostate cancer at young ages, to biologically and 
clinically more aggressive prostate tumors, and also to highly heterogeneous genetic and 
biochemical profiles among prostate tumors.  
The hypothesized main steps of tumor invasion 
Our hypothesized main steps of invasion for these normal appearing epithelial structures 
are the followings: 
1. At the early stage of prostate morphogenesis, the prostate of these patients exposed to 
external or internal insults, such as radiation, carcinogens, localized trauma, 
inflammation, or other factors, which caused permanent damages in the DNA 
structures of some primitive stem cells.  
2. Localized DNA structural damages caused the inactivation of, or defects, in basal cell 
renewal-related genes, which impaired the basal cell replenishment process to replace 
the aged or injured basal cells, resulting in a “senesced” basal cell population with 
significantly reduced functions.  
3. Localized DNA structural damages also caused the inactivation of, or defects in, 
apoptosis-, or cell cycle control related genes in the luminal cell population, which 
allow these cells to escape from programmed death, to continuously proliferate, and to 
generate their own vascular structures.  
4. Deregulated proliferation in epithelial cells and impaired self-renewal in basal cells 
resulted in the overstretch and disassociation of the basal cell layer and the basement 
membrane, which lead to focal breakdown and degeneration of these two structures.  
5. The degradation products of degenerated basal cells and the diffusible molecules of the 
overlying luminal cells function as self-epitopes to attract migration and infiltration of 
immunoreactive cells or auto-antibodies into the affected sites.  
6. The direct physical contact between IRC and degenerated basal cells results in the 
discharge of the digestive enzymes from IRC, leading to the physical destruction of 
altered basal cell layers and the local basement membrane, resulting in a focal 
disruption in these structures.  
7. As the epithelium is normally devoid of blood vessels and lymphatic ducts, and the 
basal cell layer is the sole source of several tumor suppressors, a FBCLD could lead to 
several focal alterations, including: 
a. A loss or reduction of tumor suppressors and the paracrine inhibitory functions, 
which allow the luminal cells to undergo elevated proliferation [48-52].  
b. Alterations in the permeability for oxygen or growth factors, which selectively 
triggers the exit of stem or progenitor cells from quiescence, and favor proliferation 
of cells overlying FBCLD [53-55]. 
c. The exposure of luminal cells to different cytokines, which facilitates vasculogenic 
mimicry and tumor angiogenesis [56-57].  
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d. The physical contact between luminal and stromal cells augments the expression of 
stromal MMP, facilitating epithelial-mesenchymal transition (EMT) and cell 
motility [58-60]. 
e. The physical contact between luminal and immunoreactive cells directly cause 
genomic or cellular damages that trigger a cascade reaction of malignant 
transformation [61-64].  
8. These alterations could individually or collectively trigger malignant transformation 
and stromal invasion through two different, but correlated pathways: 
a. In situ malignant transformation, in which the entire basal cell layer undergoes 
extensive degeneration and multiple focal disruptions (Fig 16) that expose the entire 
luminal cell population directly to the stroma when all surrounding myoepithelial cells 
become degenerated. Although these cells might not possess all properties of invasive 
cancer cells, the changed microenvironment may act as a second “hit” to trigger a 
cascade reaction of malignant transformation that rapidly alters the genetic and 
biochemical profiles of these cells. 
 
 
Fig. 16. Hypothesized model of in situ malignant transformation. Human prostate tissues 
double immunostained for CK34 βE12 (red) and LCA (brown). Circles identify FBCLD. 
Thick arrows identify residual basal cells. Thin arrows identify LCA-positive cells. Note that 
a vast majority of the epithelial cells are in direct physical contact with the stromal tissue. 
Also note that most LCA-positive cells are located at or near FBCLD. 300X. 
b. Progenitor-mediated cell budding, in which focal basal cell degeneration-induced 
lymphocyte infiltration causes focal disruptions in the tumor capsules, which 
selectively favor proliferation and invasion of the overlying tumor stem cells or a 
biologically more aggressive cell clone. Cells overlying FBCLD gradually increases 
in volume and form finger-like projections invading into the surrounding stroma 
(Fig 17).  
9. The above events may occur and progress immediately after the external or internal 
insults, leading to the onset of prostate cancer at young ages. On the other hand, cells of 
these normal appearing epithelial structures may become maturation-arrested after a 
few cycles of cells divisions, and remain idle until a new insult [65], representing “bad 
seeds for bad crops” at later ages.  
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Fig. 17. Hypothesized model of progenitor-mediated cell budding. Human prostate 
tissues double immunostained for CK34 βE12 (red) and proliferation marker Ki-67 
(brown). Thick arrows identify residual basal cell layers. Circles identify cell clusters 
budding from FBCLD. Note that cells budding from FBCLD are morphologically and 
immunohistochemically similar to adjacent invasive cancer cells, whereas they differ 
markedly from their adjacent counterpart within the same duct and associated with the 
residual basal cell layer. 200X.  
The main differences between our hypothesis and other theories for tumor invasion  
Based on our own and other findings, we had proposed that prostate tumor invasion is 
triggered by focal basal cell degeneration-induced aberrant infiltration of lymphocytes 
that causes focal disruptions in the tumor capsules, which selectively favor monoclonal 
proliferation and invasion of the overlying tumor stem or progenitor cells [38-39]. Our 
hypothesis differs from the enzyme theory of tumor invasion in five aspects: (1) the stage 
of tumor invasion, (2) the cellular origin of the invasive lesions, (3) the significance of the 
immunoreactive cells, (4) the significance of stromal cells, and (5) the potential approaches 
for interventions and prevention of tumor invasion. Our studies of breast tumors have 
obtained similar results and conclusions [66-74]. The new hypothesis presented in our 
current study is the expansion of our previous hypothesis with the following new points 
of views:  
A. the preservation of large clusters of genetically damaged stem or progenitor cells: Our 
previous hypothesis proposes that cell clusters overlying FBCLD represent tumor stem or 
progenitor cells, which undergo a series of immunohistochemical and morphologic changes, 
and finally transform into invasive lesions [38]. Our current hypothesis suggests that it is 
also possible that multiple genetically damaged primitive stem or progenitor cells within the 
same site may generate large duct or acinar clusters that harbor the same genetic defects. 
These clusters may be formed immediately followed the external or internal insults during 
the early stage of morphogenesis, and progress rapidly, leading to the early onset of prostate 
cancer at young ages. These clusters could also become maturation arrested at patients’ 
early ages, while they retain the potential for unlimited proliferation and multi- lineage 
differentiation, representing “bad seeds for bad crops” at later ages. Our speculation is 
supported by the results of our gene expression profiling studies, which have detected a 
over 5-fold higher expression of two stem cell lineage markers, KIT and NCOR2, in cell 
clusters overlying FBCLD compared to their adjacent counterpart associated with the 
residual basal cell layers [38] (Fig 15; Table 6).  
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B. direct transformation of the entire duct or acinar cluster into invasive lesions: Our 
previous hypothesis believes that invasive cells are derived exclusively or preferentially 
from monoclonal proliferation of stem or progenitor cells overlying FBCLD [38]. Our 
current hypothesis suggests that, in addition to monoclonal proliferation, it is possible that 
the entire duct or acinar cluster may directly transform into invasive lesions after the 
disappearance of all surrounding basal cells and the basement membrane.  
C. angiogenesis by genetically altered tumor stem cells: Our previous hypothesis proposes 
that a subset of luminal cell clusters overlying FBCLD are in direct physical continuity with 
vascular- or lymphatic duct-like structures, which allows them to progress directly to 
metastasis [38]. Our current hypothesis further suggests that some normal appearing duct or 
acinar clusters may retain genetically damaged primitive stem cells that could manufacture 
their own blood vessels or lymphatic ducts, which directly lead to metastasis. Our 
speculation is consistently supported by our immunohistochemical findings, which show 
that some of the cell clusters overlying FBCLD appear to directly invade the vascular 
structures (Fig 11). Our speculation is also supported by the results of our gene expression 
profiling studies, which have detected a over 6- and 12-fold higher expression of two 
endothelial cell markers, END and ICAM2, respectively, in cell clusters overlying FBCLD 
compared to their adjacent counterpart associated with the residual basal cell layers [38] (Fig 
15; Table 6).  
D. Potential histological origin for cancer of unknown primary site: Cancer of unknown 
primary site (CUP) is one of the 10 most frequent cancers worldwide and ranks as the 4th 
most common cause of cancer-related death [22-24]. The development of early, uncommon, 
systemic metastasis, and resistance to therapy are hallmarks of this clinical entity. Currently, 
no consensus exists on whether CUP is a group of metastatic tumors with unidentified 
primaries or a distinct entity with unique genetic/phenotypic aberrations that define it as 
“primary metastatic disease [22-24]. The normal appearing epithelial structures seen in our 
current study may represent a potential histological origin for CUP for the following 
reasons: (1) they are morphologically indistinguishable from clear-cut normal prostate 
tissues under low magnification on H & E stained sections, which allow them to escape from 
early detection, (2) they retain the property of stem cells and appear to be able to directly 
invade the stroma and vascular structures, based on our previous [38] and current studies, 
and (3) they share the same DNA phenotype with invasive prostate cancer based on 
previous reports [14-17].  
The significance of our hypothesis 
During the past 30-years, the cancer research community has been predominantly, if not 
exclusively, focused on the roles of epithelial cells in prostate tumor progression and 
invasion. Hundreds and thousands of epithelium- derived molecules have been implicated 
in the development and progression of prostate cancers. However, only prostate-specific 
antigen (PSA) has been approved and validated as a clinical diagnostic marker and only 
growth factor- and androgen receptor-based therapeutic agents have been approved and 
validated for the clinical trials for prostate cancers. In addition, none of epithelium-derived 
markers has significant value in predicating the tumor biology or invasiveness, or in 
identifying the specific individuals with pending prostate cancer, or at higher risk to 
develop prostate cancer. These findings strongly suggest that the epithelium alone is very 
unlikely to be sufficient to trigger tumor progression and invasion. 
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Our hypothesis, if confirmed, could have several significant implications. Scientifically, it 
could lead to a new direction to explore novel approaches for early detection, intervention, 
and prevention of prostate tumor invasion. For example, as non-disrupted basal cell layers 
have significant inhibitory functions on epithelial cell growth, the development of 
therapeutic agents to stimulate basal cell growth or regeneration may provide a more 
effective approach for treatment and prevention of prostate cancer invasion. Clinically, it 
could potentially bring the following benefits: 
1. Better recognition of these clusters may avoid misdiagnosis and facilitate early 
interventions, which may significantly improve prognosis.  
2. Double immunohistochemical staining to assess the physical integrity of the basal cell 
layer, or an quantitative measurement of basal cell degeneration-related molecules in 
the blood or biopsies, may facilitate early identification of individuals at greater risk to 
develop invasive lesions.  
3. As genetic alterations not only define the scope and extent of, but also precede, both 
biochemical and morphological alterations, elucidation of the genetic profile of these 
normal appearing duct or acinar clusters may lead to the identification of the specific 
molecules that trigger the initiation of prostate carcinogenesis, progression, and 
invasion.  
4. Currently, the only established approach to monitor prostate tumor progression is 
repeat biopsy [28-31], which is costly and painful. Our technical approaches of assessing 
the physical and functional status of the basal cells may be used as a more reliable 
alternative for repeat biopsy to monitor tumor progression and invasion.  
More importantly, our hypothesis may be also applicable to progression and invasion of 
other epithelium derived tumors.  
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